Largest Covid Vaccine Study Yet Finds Links to Health Conditions


by Jason Gale Feb 20, 2024 Microsoft Start (Bloomberg) — Vaccines that protect against severe illness, death and lingering long Covid symptoms from a coronavirus infection were linked to small increases in neurological, blood, and heart-related conditions in the largest global vaccine safety study to date. The rare events — identified early in the pandemic — included a higher […]

Determinants of COVID-19 vaccine-induced myocarditis


Jessica Rose, Nicolas Hulscher https://orcid.org/0009-0008-0677-7386 nichulscher@gmail.com, and Peter A. McCulloughView all authors and affiliations, https://doi.org/10.1177/20420986241226566 Abstract Background: Following the roll-out of the Pfizer-BioNTech BNT162b2, Moderna mRNA-1273, and Janssen Ad26.COV2.S coronavirus disease 2019 (COVID-19) injections in the United States, millions of individuals have reported adverse events (AEs) using the vaccine adverse events reports system (VAERS). The objective of this analysis is to describe […]

U.S. Navy Department Data Showing Alarming Increase in Heart-Related Issues Among Pilots Following COVID-19 Vaccination


By Jim Hᴏft Nov. 28, 2023 The Gateway Pundit Since the introduction of the experimental COVID-19 vaccines, The Gateway Pundit has been covering numerous studies from health professionals, revealing startling findings that mRNA COVID-19 vaccines are linked to the rapid onset of heart-related problems in individuals across all age groups. On Monday, Lieutenant Ted Macie, an active-duty officer […]

Conflicting Evidence Of mRNA Technology Raises Serious Concerns About Rush For Use In New Vaccine Development


Authored by Megan Redshaw via The Epoch Times, FRIDAY, SEP 01, 2023 The U.S. government and pharmaceutical companies are investing a substantial amount to develop new mRNA vaccines for infectious diseases and cancer, fueling a lucrative mRNA platform valued at $136.2 billion. A newly established White House program announced on Aug. 23 that it is granting a […]

Bivalent Covid-19 Vaccines — A Cautionary Tale .


List of authors. Paul A. Offit, M.Dt of authors. Paul A. Offit, M.D New England Journal of Medicine January 23, 2023 in Wuhan, China. Two months later, the original strain of SARS-CoV-2, called the Wuhan-1 or ancestral strain, was isolated and sequenced. It was now possible to make a vaccine. All the vaccines, including the […]

Psoriasis and COVID-19 Vaccine: What to Know


Authors: Christine Zink, MD  Updated on October 19, 2022 Medically reviewed by Casey Gallagher, MD Very Well Health Oct 19, 2022 Psoriasis is a skin disorder characterized by thick, inflamed patches with silvery scales. It is a complex autoimmune and inflammatory disorder in which immune cells inappropriately attack the skin cells, leading to rapid replacement and buildup.1 Psoriasis […]

FDA restricts J&J’s COVID-19 vaccine due to blood clot risk


Authrsors: Associated Press WASHINGTON (AP) — U.S. regulators on Thursday strictly limited who can receive Johnson & Johnson’s COVID-19 vaccine due to the ongoing risk of rare but serious blood clots. The Food and Drug Administration said the shot should only be given to adults who cannot receive a different vaccine or specifically request J&J’s vaccine. U.S. authorities […]

Vascular and organ damage induced by mRNA vaccines: irrefutable proof of causality


Authors: Michael Palmer, MD and Sucharit Bhakdi, MD August 19, 2022 Popular Science This article summarizes evidence from experimental studies and from autopsies of patients deceased after vaccination. The collective findings demonstrate that mRNA vaccines don’t stay at the injection site by instead travel throughout the body and accumulate in various organs, mRNA-based COVID vaccines […]

FDA limits use of J&J vaccine over rare blood clots


Authors:  PETER SULLIVAN – 05/05/22 THE HILL The Food and Drug Administration (FDA) on Thursday announced that it is limiting the authorization for the Johnson & Johnson COVID-19 to people who cannot or will not get other versions of the vaccine, citing the risk of rare blood clots.   The authorization for the J&J vaccine, also […]

Pfizer-BioNTech Vaccine Much Weaker in Kids Against Omicron and More


Authors: Mark Terry Published: Mar 01, 2022  BIOSPACE Pfizer-BioNTech Vaccine Only 12% Effective Against Omicron in 5-11-Year-Olds  In a new study that is yet to be peer-reviewed, the New York State Department of Health found that the Pfizer–BioNTech vaccine was only about 12% effective for children ages 5 to 11 years against the Omicron variant. In that age group, it […]